B-cell
Investigational CD19-Directed CAR-T Therapy Granted FDA’s RMAT Designation
Leah LawrenceAcute Lymphoblastic Leukemia | November 16, 2022
The therapy is being investigated for adults with relapsed/refractory B-cell acute lymphoblastic leukemia.
Read More
Positive Early Data Announced for NK Cell Therapies
Leah LawrenceAcute Myeloid Leukemia | February 2, 2023
Thee candidates have early single-agent activity in heavily pretreated patients with hematologic malignancies.
Read More
Advertisement
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Editorial Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |